This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main purpose of this study is to find out if alendronate plus calcium and vitamin D is well tolerated, effective and safe to treat bone loss in persons with HIV infection compared to calcium and vitamin D alone.
Showing the most recent 10 out of 782 publications